PaperComparison of continuous infusion and bolus administration of ifosfamide in children
References (25)
Metabolism of oxazaphosphorines
Pharmacol Ther
(1988)- et al.
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide
Biochem Pharmacol
(1994) - et al.
Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde
Biochem Pharmacol
(1992) - et al.
Dechloroethylation of ifosfamide and neurotoxicity
Lancet
(1986) - et al.
Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma
J Chromatog Biomed Appl
(1992) - et al.
Ifosfamide: A weekly dose fractionated schedule in bronchogenic carcinoma
Cancer Treat Rep
(1981) Ifosfamide in paediatric oncology
Anti-cancer Drugs
(1991)- et al.
Dosing and side-effects of ifosfamide plus mesna
J Cancer Res Clin Oncol
(1991) - et al.
Response to ifosfamide and Mesna: 124 previously treated patients with metastatic or unresectable sarcoma
J Clin Oncol
(1989) - et al.
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer
J Cancer Res Clin Oncol
(1991)
Studies on the human pharmacokinetics of isophosphamide (NSC 109724)
Cancer Treat Rep
(1976)
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility
J Cancer Res Clin Oncol
(1991)
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.